Plain-English translation of NCT07420907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that asks people with heart conditions—such as heart failure, high blood pressure, valve disease, or cardiomyopathy—to wear Prolaio digital health devices that continuously monitor their heart and cardiovascular health. Researchers will collect this physiological data over time to better understand how these conditions naturally progress and what patterns emerge in patients' daily lives.
Many heart conditions change gradually over months and years, but doctors often only see a snapshot during office visits. By collecting continuous data from wearable devices, researchers hope to gain a much clearer picture of how these conditions actually evolve in real life, which could lead to better ways to predict, prevent, or manage heart disease.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would wear the Prolaio digital health device(s) regularly to monitor your heart and cardiovascular function. The study will collect the physiological data these devices record over an extended period as you go about your normal life. You'll need to be able to comply with wearing the device and returning for any study-related visits, though the exact schedule would be explained to you before enrollment.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Sponsor
Prolaio
Enrollment target
~5,000 participants
Started
October 2025
Primary completion
October 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Study Team OCORO Study
Prolaio
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.